Le Lézard
Classified in: Health
Subject: WOM

Boston IVF Expands National Network and Elevates Access to Fertility Care in Rochester, New York


Boston IVF's new fertility center in Rochester, NY represents a significant development for individuals pursuing parenthood and offers benefits to the broader local community.

ROCHESTER, N.Y., Nov. 6, 2023 /PRNewswire-PRWeb/ -- Boston IVF, a global leader in fertility treatment, is pleased to announce the acquisition of Rochester Regional Health's Fertility Care Center into its expanding national fertility network.

"We are delighted to have Dr. Mroueh and the exceptional team in Rochester join Boston IVF's network and continue to provide outstanding care and services to patients in Rochester and Western NY." ? David Stern, CEO of Boston IVF

This thoughtful addition reinforces Boston IVF's commitment to providing world-class fertility treatments and family building care to individuals in the Greater Rochester Region and across Western New York. Under the Boston IVF umbrella, the established fertility team in Rochester remains unchanged, now bolstered by the extensive resources of the Boston IVF Fertility Network.

Starting November 2, 2023, the renowned reproductive endocrinologist, Dr. Jamil Mroueh, will maintain his leadership of the dedicated team, ensuring the provision of a wide range of fertility services to individuals and couples as they embark on their parenthood journey at the current fertility center located at 1561 Long Pond Road in Rochester, NY.

These services encompass initial consultations, follow-up appointments, thorough treatment management, intrauterine insemination procedures (IUI), ultrasound and blood work monitoring, and more. IVF procedures and egg freezing, which involve egg retrievals and embryo transfers, will be performed at Boston IVF's fertility center in Syracuse, NY.

In New York, Boston IVF's influence is evident through a network of state-of-the-art IVF centers in Albany and Syracuse, featuring a team of highly skilled and empathetic professionals. Comprising reproductive endocrinologists, fertility nursing experts, embryologists, and scientists, and a dedicated support staff, they share a common commitment to assisting patients in realizing their aspirations of parenthood.

Since its inception in 1986, Boston IVF has contributed to the birth of over 150,000 babies through its treatments and now manages more than 30 locations across the United States.

"Boston IVF's extensive experience, scientific expertise, and technological capabilities empower our team to leverage invaluable national treatment data, resulting in the highest quality reproductive care to local patients in Rochester, New York," stated David Stern, CEO of Boston IVF. "We are delighted to have Dr. Mroueh and the exceptional team in Rochester join Boston IVF's network and continue to provide outstanding care and services to patients in Rochester and Western NY."

Additionally, Haryanto Hokianto, MBA, Chief Development Officer at Boston IVF, highlighted, "With a rich history spanning over four decades, Rochester Regional Health has steadfastly dedicated itself to serving the local community, especially those embarking on the journey to expand their families. Boston IVF's commitment to patients and their parenthood journey aligns closely with this shared core value."

Follow Boston IVF on Instagram

Follow Boston IVF on LinkedIn

Follow Boston IVF on Facebook

Follow Boston IVF on Twitter

ABOUT BOSTON IVF

Boston IVF is one of the largest and most experienced fertility networks in the United States, with over 150,000 babies born since 1986. Founded as one of the nation's first private practice IVF centers, the Boston IVF network now spans 30 reproductive endocrinologists across 30 centers throughout the country, including New York. Renowned for its innovative reproductive technologies and research, Boston IVF continues to lead the way in fertility care and training the next generation of fertility experts.

Media Contact
Zoe Marzi, Boston IVF, 1 978-604-0392, [email protected], www.bostonivf.com

Twitter

 

SOURCE Boston IVF


These press releases may also interest you

at 16:15
enGene Holdings Inc. , a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), today announced the election of Paul Hastings and Wouter...

at 16:12
Profound Medical Corp. ("Profound" or the "Company") is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the "Meeting"). A total of 15,336,388 common shares, representing 62.78% of the...

at 16:10
Bruker Corporation today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock. The dividend will be paid on June 17, 2024 to stockholders of record as...

at 16:10
OmniAb, Inc. today announced its participation in the 20th Annual PEGS Boston ? The Essential Protein & Antibody Engineering Summit underway at the Omni Hotel. Earlier today the Company presented an overview of xPloration, a high-throughput single...

at 16:10
QuidelOrtho Corporation has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho's commitment to strengthening supply chain resilience and elevating the...

at 16:05
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today detailed data presented by its partners at the University of California, San Francisco...



News published on and distributed by: